Proteinopathies Expression in Skin of Neurodegenerative Disorders

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age45+
SponsorUniversidad Autonoma de San Luis Potosí

About this trial

The goal of this observational study is to compare the aggregation pattern of proteinopathies (alpha-synuclein, amyloid-beta, phosphorylated tau and transactive response DNA -binding protein 43 \[TDP43\]) in skin biopsies of patients with a neurodegenerative disease like Alzheimer's disease, frontotemporal lobe dementia, Parkinson's disease, atypical Parkinsonism, amyotrophic lateral sclerosis or normal pressure hydrocephalus. The main question it aims to answer is:

* Is there a specific pattern of aggregation of proteinopathies in skin biopsies in each neurodegenerative disease in comparison to healthy control subjects?

Skin biopsies will be analyzed using immunohistochemistry and immunofluorescence for detection of alpha-synuclein, amyloid-beta, phosphorylated tau and TAR DNA binding protein 43, and the aggregation patterns will be compared between patients with a neurodegenerative disease vs patient with normal pressure hydrocephalus vs healthy control subjects.

Eligibility criteria

Qualifiers

Patients 45 years and older

Men and women

Patients diagnosed with Alzheimer's disease, frontotemporal lobe dementia, Parkinson's disease, atypical Parkinsonism, amyotrophic lateral sclerosis or normal pressure hydrocephalus

Patients that voluntarily accept to participate in the study and accept the consent form

Disqualifiers

Patients or controls that have a personal history of cerebrovascular disease, psychiatric disease, post traumatic dementia or HIV related dementia

Patients in which the diagnosis is not clear or hasn't been confirmed

Patients or controls that have a neuroinfection

Patients or controls that a diagnosed skin disease

Trial design

Treatments tested in this trial

  • Immunohistochemistry and immunofluorescence

Treatment groups

40 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Universidad Autonoma de San Luis Potosí

Lead sponsor

Hospital Central "Dr. Ignacio Morones Prieto"

Collaborator